Krishna Institute of Medical Sciences Ltd (KIMS) reported consolidated revenue of ₹9.98 billion and net profit of ₹534 million for the December 2025 quarter. The results highlight steady growth in healthcare services, supported by patient volume expansion, operational efficiency, and strong demand across its network of hospitals in India.
Krishna Institute of Medical Sciences Ltd (KIMS), one of India’s leading healthcare providers, announced its financial results for the quarter ended December 31, 2025. The company posted consolidated revenue from operations of ₹9.98 billion and consolidated net profit of ₹534 million, reflecting resilience in the healthcare sector.
The performance was driven by higher patient inflows, expansion of specialty services, and efficient cost management across its hospital network. Analysts note that KIMS continues to benefit from rising healthcare demand in tier-I and tier-II cities, supported by its focus on affordability and quality care.
Key Highlights:
-
Revenue Performance: Consolidated revenue stood at ₹9.98 billion in Q3 FY26.
-
Profitability: Net profit reported at ₹534 million.
-
Growth Drivers: Increased patient volumes and specialty service expansion.
-
Operational Strength: Efficiency in cost management supported margins.
-
Market Outlook: Continued focus on affordable, quality healthcare across India.
KIMS’ Q3 results reaffirm its strong fundamentals and strategic positioning, underscoring its role as a trusted healthcare provider in India’s rapidly growing medical services industry.
Sources: Bombay Stock Exchange (BSE), National Stock Exchange (NSE), Economic Times, Mint, Business Standard